Charles River Laboratories International (CRL) Interest & Investment Income (2009 - 2026)

Charles River Laboratories International's Interest & Investment Income history runs 17 years deep, the most recent figure standing at $1.0 million for Q4 2025.

• In Q4 2025, Interest & Investment Income fell 44.58% year-over-year to $1.0 million; the TTM figure through Dec 2025 stood at $4.9 million (down 42.39% YoY), while the FY2025 annual figure was $4.9 million, down 42.39% from the prior year.
• Interest & Investment Income for Q4 2025 stood at $1.0 million, down from $1.4 million in the prior quarter.
• The five-year high for Interest & Investment Income was $3.0 million in Q2 2024, with the low at $35000.0 in Q1 2021.
• The 5-year median for Interest & Investment Income is $1.1 million (2025), against an average of $1.0 million.
• The sharpest annual moves came in 2021 and 2023: Interest & Investment Income plunged 88.92% in 2021, then soared 1025.41% in 2023.
• Charles River Laboratories International's Interest & Investment Income stood at $309000.0 in 2021, then rose by 11.0% to $343000.0 in 2022, then soared by 363.85% to $1.6 million in 2023, then advanced by 15.34% to $1.8 million in 2024, then plunged by 44.58% to $1.0 million in 2025.
• Business Quant data shows CRL's Interest & Investment Income at $1.0 million in Q4 2025, $1.4 million in Q3 2025, and $1.1 million in Q2 2025.